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The calponin homology-associated smooth muscle protein (CHASM) can modulate muscle contrac-
tility, and its biological action may involve an interaction with the contractile ﬁlament. In this study,
we demonstrate an interaction between CHASM and tropomyosin. Deletion constructs of CHASM
were generated, and pull-down assays revealed a minimal deletion construct that could bind tropo-
myosin. Removal of the calponin homology (CH) domain or expression of the CH domain alone did
not enable binding. The interaction was characterized by microcalorimetry with a dissociation con-
stant of 2.0  106 M. Confocal ﬂuorescence microscopy also showed green ﬂuorescent protein
(GFP)–CHASM localization to ﬁlamentous structures within smooth muscle cells, and this targeting
was dependent upon the CH domain.
Structured summary:
MINT-7966126: CHASM (uniprotkb:Q99LM3), Tropomyosin alpha (uniprotkb:P04268) and Tropomyosin
beta (uniprotkb:P19352) physically interact (MI:0915) by isothermal titration calorimetry (MI:0065)
MINT-7966073: CHASM (uniprotkb:Q99LM3) physically interacts (MI:0914) with Tropomyosin beta (uni-
protkb:P58776) and Tropomyosin alpha (uniprotkb:P58772) by pull down (MI:0096)
MINT-7966187: Tropomyosin alpha (uniprotkb:P04268) and Tropomyosin beta (uniprotkb:P19352) phys-
ically interact (MI:0915) with CHASM (uniprotkb:Q99LM3) by pull down (MI:0096)
MINT-7966090: CHASM (uniprotkb:Q99LM3) binds (MI:0407) to Tropomyosin alpha (uniprotkb:P04268)
by pull down (MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction to the other smoothelin proteins and a C-terminal, type-2 calponinThe calponin homology-associated smooth muscle protein
(CHASM, also known as smoothelin-like 1) is a novel member of
the smoothelin family of muscle proteins [1] and is able to modu-
late the contractile activity of both smooth and skeletal muscle [2].
Based on alignments with the smoothelin proteins, CHASM can be
divided into two separate functional regions (Fig. 1A): an N-termi-
nal unfolded region (aa 1–361) with minimal sequence similaritychemical Societies. Published by E
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ld).homology (CH) domain (aa 361–459) [3]. Although CHASM
showed the highest sequence similarity to smoothelins in the
C-terminal type-2 CH-domain (residues 347–459) [1,3], there
was also similarity within a tropomyosin-binding domain (TBD)
of smoothelin that was found to be necessary for the localization
of the protein to actin-containing ﬁlaments [4].
While analyses of mice lacking smoothelin isoforms have re-
vealed critical roles for these proteins in intestinal [5] and arterial
smooth muscle contractility [6], the speciﬁc biological role of
CHASM in muscle remains poorly deﬁned. The CHASM protein ap-
pears to modulate the contractile activity of smooth and striated
muscles [1,2,7], and enhanced vascular and skeletal adaptations to
exercise have been identiﬁed in Smtnl1/ mice [2]. Most notably,
aortic smooth muscle from Smtnl1/ animals exhibited enhanced
vasorelaxation before exercise, similar in extent to that achieved
after endurance training in wild-type animals. Furthermore, the
contractile response of Smtnl1/ aortic smooth muscle to a-adren-
ergic agonists was greatly attenuated. Overall, these experimentslsevier B.V. All rights reserved.
Fig. 1. The domain structure of CHASM and smoothelin proteins. (A) The tropomyosin-binding domain (TBD) of smoothelin-B is shown as a hatched box. The calponin
homology (CH) domains are shown as cylinders. The C-terminal alternative splice variant region of smoothelin-B is in dark gray, and the Ser-301 phosphorylation site of
CHASM as ‘P’. Mouse troponin T from heart muscle (TnT cardiac, P50752) and from fast skeletal muscle (TnT fast, AAF01502) were aligned to mouse smoothelin-B
(AAD29628.2) and CHASM (NP_077192) in the region surrounding the TBD. In (B), the CHASM truncations used to assess tropomyosin binding are illustrated. The putative
tropomyosin-binding domain (TBD) of CHASM is shaded in white and the CH domain is grey.
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contractile activity.
In this study, we provide the ﬁrst evidence that CHASM can
bind to tropomyosin and describe the structural determinants re-
quired for the interaction. In the comparison of primary sequences
between CHASM and smoothelins, we focused on the TBD region
that was previously demonstrated to drive the localization of
smoothelin to actin/tropomyosin-containing ﬁlaments in cells
[4]. Interestingly, the interaction of CHASM with tropomyosin did
not require this putative TBD sequence but instead was dependent
on the presence of the complete CH domain sequence as well as a
section of the disordered, ‘‘central core region” (i.e., residues
195–361). Finally, the localization of green ﬂuorescent protein
(GFP)–CHASM fusions within A7r5 smooth muscle cells reﬂects
the tropomyosin-binding properties of CHASM and also indicate
that the intracellular localization of CHASM to ﬁlamentous struc-
tures was dependent on the CH domain.
2. Materials and methods
2.1. Materials
Puriﬁed chicken gizzard tropomyosin was kindly provided by Dr.
MichaelWalsh (University of Calgary). An anti-CHASMantibodywas
provided by Dr. Timothy Haystead (Duke University). PreScission
protease, glutathione-Sepharose, pGEX-6P1 and pcDNA3.1 plasmids
were all purchased from GE Healthcare (Piscataway, NJ). All other
chemicals were of reagent grade and purchased from VWR Scientiﬁc
(Edmonton, AB) or Sigma Chemical Company (St. Louis, MO).
2.2. Cloning and expression of CHASM constructs
Various CHASM fragments (Fig. 1B) were ampliﬁed from
I.M.A.G.E. clone 3593616 (Research Genetics) by standard PCRtechniques with primers designed from the mouse CHASM se-
quence: DCH, bp 1–1038/aa 1–346; DCT, bp 1–1083/aa 1–361;
DTBD/DCT, bp 583–1083/aa 195–361; DNT, bp 427–1377/aa
143–459; DTBD, bp 583–1377/aa 195–459 and CH domain, bp
1036–1377/aa 346–459. See supplementary Table 1 for a list of
primers used. Glutathione-S-transferase (GST) fusion proteins
were expressed in Escherichia coli BL21 (DE3) and isolated with
glutathione-Sepharose resin. In some cases, the GST-tag was re-
moved by cleaving ‘on-column’ with PreScission Protease.
2.3. Identiﬁcation of tropomyosin as a CHASM binding protein in ileal
smooth muscle extract
We performed afﬁnity column-based isolations of CHASM-
interacting proteins from rabbit ileum. Smooth muscle tissue was
isolated, homogenized in STE buffer (150 mM NaCl, 50 mM Tris,
1 mM EDTA, pH 7.2) and clariﬁed by centrifugation. The ileal ex-
tract was incubated with GST–CHASM, GST–CHASM-DCH or GST
proteins immobilized to glutathione-Sepharose. After extensive
washing, CHASM-binding proteins were eluted with 0.5 M NaCl
in STE and resolved by SDS–PAGE. Protein bands were excised from
the gel and subjected to ‘in-gel’ trypsin digestion [8]. Extracted
peptides were de novo sequenced by tandem mass spectrometry
(MS/MS) and searched against the PIR1 database using the FASTS
algorithm [9].
2.4. Binding of tropomyosin to immobilized GST–CHASM mutants
Further reﬁnement of the tropomyosin-binding region was ob-
tained with various GST–CHASM truncation proteins (Fig. 1B).
GST–CHASM proteins were immobilized on glutathione-Sepharose
and then incubated with puriﬁed chicken gizzard tropomyosin.
After extensive washing with STE buffer containing 350 mM NaCl,
CHASM-bound tropomyosin was eluted with SDS–PAGE loading
Fig. 2. CHASM binds to tropomyosin from ileum extract. GST–CHASM, GST–
CHASM-DCH or GST were immobilized on glutathione-Sepharose resin and
incubated with rabbit ileum extract; proteins bound to the various GST-fusion
proteins were eluted with 0.5 M NaCl. As a loading control, glutathione (GSH,
10 mM) was applied to the columns to assess total GST-fusion protein used as ‘bait’.
The location of GST–CHASM (WT), GST, GST–CHASM-DCH and tropomyosin (TM)
are indicated on the right, molecular weight markers are indicated on the left.
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antibody; TM311, Sigma). The binding experiment was repeated
using Alexa-Fluor680-labeled tropomyosin to visualize both tropo-
myosin isoforms. After binding and elution, the recovered ﬂuores-
cent-labeled tropomyosin was subjected to SDS–PAGE, transferred
onto nitrocellulose and visualized using a STORM imager.
2.5. ‘Far-western’ overlay of ﬂuorescent-labeled tropomyosin with
GST–CHASM mutants
The tropomyosin–CHASM interaction was also examined with a
‘far-western’ overlay using Alexa-Fluor680-labeled tropomyosin.
The various puriﬁed CHASMmutants were separated by SDS–PAGE
and transferred onto nitrocellulose. The membrane was blocked
overnight in 5% (w/v) non-fat milk in phosphate-buffered saline
(PBS) followed by incubation for 3 h at 4 C with 10 lg/ml Alexa-
Fluor680-labeled tropomyosin in PBS plus 5 mg/ml bovine serum
albumin. After brief washing in PBS, Alexa-Fluor680-labeled tropo-
myosin was detected with a STORM imager.
2.6. Binding of CHASM to immobilized tropomyosin-Sepharose
Tropomyosin or Tris–HCl (as control) was covalently bound to
CNBr-activated Sepharose (GE Healthcare) according to the manu-
facturer’s instructions. Freshly puriﬁed CHASM or CHASM-DCT in
binding buffer (25 mM Tris pH 7.2 with 0.1% (v/v) b-mercap-
toethanol) was incubated with control- or tropomyosin-Sepharose
for 2 h at 4 C. After extensive washing with binding buffer plus
150 mM NaCl, bound CHASM proteins were detected by Western
blotting.
2.7. Isothermal titration calorimetry (ITC) measurements
All ITC experiments were carried out on a MicroCal VP-ITC
microcalorimeter over a range of temperatures (15–37 C). Solu-
tions of CHASM–CH, CHASM-DTBD/DCT or CHASM-DTBD were
sequentially injected into a sample cell containing tropomyosin
in ITC buffer (20 mM HEPES, pH 7.5, 50 mM KCl and 1 mM
b-mercaptoethanol). The controls for the heat of dilution were
obtained by titrating each CHASM protein into the ITC buffer
in the absence of tropomyosin. Protein concentrations were
determined using the predicted molecular extinction coefﬁcient
(e280): CHASM-DTBD, 24,200 cm1 M1; CHASM-DTBD/DCT,
12,490 cm1 M1; CHASM–CH, 18,450 cm1 M1 and tropomyosin
(assuming 100% a/b heterodimer), 10,430 cm1 M1. The data was
ﬁt to a one-site binding model (MicroCal Origin software) after the
subtraction of the heat of dilution control to obtain the dissocia-
tion constant (Kd).
2.8. Cell culture, expression of GFP–CHASM constructs and microscopy
Rat vascular smooth muscle cells (A7r5 cells, ATCC Nr.
CRL-1444™) were maintained in Dulbecco’s Modiﬁed Eagle
Medium, 10% fetal bovine serum, 1% penicillin/streptomycin (Invit-
rogen) in a humidiﬁed tissue culture incubator at 37 C with 5%
CO2. The cells were transiently transfected at passage 15–20 with
GFP–CHASM, GFP–CHASM-DCT or empty vector (GFP only) in
pcDNA3.1 using Fugene 6 (Invitrogen). The cells were split after
2 days and re-plated onto glass coverslips. The following day, cells
were ﬁxed with 4% paraformaldehyde in PBS (pH 7.4), mounted
with ProLong Gold Antifade Media (Invitrogen) and viewed using
an Olympus Fluoview 1000 laser scanning confocal microscope.
Localization of GFP–CHASM, GFP–CHASM-DCT and GFP was dem-
onstrated by direct ﬂuorescence; stacks of optical sections were ac-
quired by sequential acquisition and analyzed with FVv1.7a
software. A rhodamine phalloidin-based F-actin Visualization Kit(Cytoskeleton Inc., Denver, CO) was used per the manufacturer’s
instructions to visualize F-actin.
3. Results
3.1. Identiﬁcation of CHASM as a tropomyosin-binding protein
After capture of rabbit ileal smooth muscle proteins, a band
with an approximate molecular weight of 40 kDa was highly en-
riched with the GST–CHASM resin but not with the control GST
column (Fig. 2). Four tryptic peptides (DSLLAADEAAAK, m/z
687.8, 2+; DDLEETLASAK, m/z 703.4, 2+; DLEEEVLQ, m/z 622.4, 2+
and VLLEGELE, m/z 585.9, 2+) were sequenced de novo with tan-
dem MS/MS. The two best identities with expectation values of
1.6  e6 and .052 were the a and b subunits of tropomyosin,
respectively. The next best match had an expectation value of
3.5. Thus, from these results we concluded that CHASM could bind
to the smooth muscle a/b tropomyosin heterodimer. When a
CHASM construct lacking the CH domain (i.e., GST–CHASM-DCH)
was used, a minimal amount of tropomyosin was recovered
(Fig. 2). This was the ﬁrst evidence to suggest that the CH domain
was important for the interaction of CHASM with tropomyosin.
3.2. Tropomyosin binding to CHASM requires the CH-domain but not a
degenerate TBD
An alignment of the TBDs of skeletal muscle and cardiac tropo-
nin T (TnT), smoothelin-B and CHASM conﬁrmed that there was
some minor sequence similarity in the TBD of TnT and smoothelin
[4]; however, the CHASM sequence that corresponds to the
smoothelin TBD is quite divergent (Fig. 1A), with only six charged
residues conserved. A series of CHASM fragments (Fig. 1B) were
used for in vitro binding experiments and demonstrated that
tropomyosin-binding to CHASM was not dependent upon the
TBD sequence (Fig. 3A) since a CHASM construct lacking this do-
main could still effectively interact with tropomyosin. CHASM con-
structs that included the central core region and the CH domain
(i.e., CHASM-DTBL and CHASM-DNT) provided maximal binding;
however, the CH domain in isolation was not capable of binding
to tropomyosin. Preliminary data collected from 1H, 15N-HSQC
NMR spectra of CHASM-DTBD suggest that many residues within
a-helix-I of the CH domain are involved in intramolecular
interactions with the central core region to generate structure
(MacDonald and Vogel, unpublished data). So, a CHASM construct
Fig. 3. CHASM binding with tropomyosin requires the complete CH domain sequence and the central core region. (A) GST-tagged, full-length CHASM (WT) or its truncation
variants (100 lg) were bound to glutathione-Sepharose resin and puriﬁed chicken gizzard tropomyosin (100 lg) was added. The a isoform of tropomyosin was detected by
western blotting. (B) Both a and b isoforms were detected when the pull-down was performed with ﬂuorescent-labeled tropomyosin, followed by SDS–PAGE and transfer to
nitrocellulose. Fluorescent-labeled tropomyosin was detected using a STORM imager. (C) The interaction between puriﬁed GST-tagged CHASM variants and tropomyosin
(10 lg/ml) was detected by a ‘far-western’ overlay. (D) CHASM or CHASM-DCT proteins were bound to immobilized tropomyosin-Sepharose or control-Sepharose (blank).
After extensive washing, bound CHASM proteins were eluted and detected by western blotting. In all cases, the images are representative of n = 3 separate pull-down or far-
western experiments. The locations of a and b isoforms of tropomyosin are indicated on the right, molecular weight markers are on the left. Total protein was stained using
Coomassie or Amido black stain to verify equal loading.
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generated and used to assess tropomyosin-binding properties.
Weak binding of tropomyosin was observed for the CHASM-
DTBD/DCT constructs (Fig. 3A and B) that possessed this C-termi-
nal deletion, suggesting that residues within the remainder of the
CH domain act to stabilize the association. The experiment was
repeated with ﬂuorescent-labeled tropomyosin (Fig. 3B). Both
a- and b-isoforms of tropomyosin were detected, and these results
were in agreement with our initial identiﬁcation of both a- and
b-tropomyosin isoforms by tandem MS/MS. ‘Far-western’ overlays
were performed with immobilized CHASM-DTBD, CHASM-DNT
or CHASM-DTBD/DCT and ﬂuorescent-labeled tropomyosin
(Fig. 3C). In agreement with our previous results, tropomyosin
was found to associate with CHASM-DTBD and CHASM-DNT, but
not with CHASM-DTBD/DCT. Finally, immobilized a/b-tropomyo-
sin-Sepharose was generated to explore whether CHASM could
be captured using this support as bait (Fig. 3D). In this case, CHASM
was readily recovered from tropomyosin-Sepharose while the par-
tial deletion of CH domain sequence ablated binding.
3.3. ITC characterization of the tropomyosin–CHASM interaction
ITC was used to quantitatively characterize the binding of
CHASM-DTBD to puriﬁed chicken gizzard tropomyosin (Fig. 4).
The addition of CHASM-DTBD to tropomyosin caused an exother-
mic reaction with a calculated Kd of 2.0  106 M whereas the
addition of CHASM-DTBD/DCT or CHASM–CH proteins did not eli-
cit any heat of binding, suggesting either very weak or absence of
binding. The ﬁndings are consistent with the results of pull-down
experiments outlined in the preceding section and suggest anabsence of tropomyosin-binding for CHASM constructs lacking
the complete CH domain sequence.
3.4. The CH domain directs CHASM intracellular localization
Upon evaluation by confocal microscopy (Fig. 5), GFP–CHASM
appeared to associate in longitudinal arrays with F-actin-contain-
ing ﬁlaments throughout the interior of the A7r5 cells and ex-
tended to the cell periphery. These results are consistent with
previous reports that described the localization of other smooth-
elin family members to ﬁlamentous structures in mouse ﬁbroblasts
(REF52 [10] and NIH3T3 [4] cells) and primary porcine vascular
smooth muscle cells [11]. In contrast, GFP–CHASM-DCT was found
diffusely distributed throughout central regions of the cell interior
with some localization to the leading edge of the cell. The lack of a
ﬁlamentous ﬂuorescence pattern in A7r5 cells expressing the
CHASM-DCT fusion protein was in general agreement with our
earlier biochemical results that suggest a disruption of tropomyo-
sin-binding properties. As a control, GFP was expressed, and ﬂuo-
rescence was distributed with diffuse intensity throughout the
cell interior. Western blot analysis with anti-CHASM antibody re-
vealed expression of fusion proteins that migrated at their pre-
dicted sizes, and probing of cell lysates with an anti-GFP
antibody detected only the appropriate GFP fusion proteins (data
not shown).
4. Discussion
Tropomyosin has been reported to bind to many proteins with a
multiplicity of structural modes [12,25]. Known binding partners
Fig. 4. Isothermal titration calorimetry reveals that CHASM binding to tropomyosin
requires the complete CH domain sequence. (A) The calorimetric traces are
displayed for the titrations obtained for sequential injection of 0.53 mM CHASM-
DTBD (i), 0.34 mM CHASM-DTBD/DCT (ii) and 0.33 mM CHASM–CH (iii) into
34.5 lM tropomyosin in 20 mM HEPES buffer (pH 7.5) containing 50 mM NaCl and
1 mM b-mercaptoethanol at 25 C. (B) The derived binding isotherms for the
tropomyosin binding to CHASM-DTBD (d), CHASM-DTBD/DCT (h) and CHASM-CH
(s) are presented.
Fig. 5. Deletion of CH domain sequence alters the intracellular localization of
CHASM in rat vascular smooth muscle cells. A7r5 cells were transiently transfected
with pcDNA3.1 encoding GFP–CHASM (A), GFP–CHASM-DCT (B) or GFP (C) alone.
Filamentous actin was also stained in untransfected cells with rhodamine phalloi-
din (D). Cells were grown on coverslips, ﬁxed and mounted as described in Material
and methods. Individual optical sections are displayed and were captured using an
Olympus Fluoview 1000 laser scanning confocal microscope equipped with
UPlanApo N, 60/1.42 NA oil objective; scale bars = 10 lm.
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teins [18,19], the LIM protein enigma [20], Rad GTPase [21], gelso-
lin [22] and tropomodulin [23]. Intriguingly, calponin itself was
previously demonstrated to possess tropomyosin-binding charac-
teristics [15–17]. Although the speciﬁc interaction surface was
not precisely deﬁned, tropomyosin-binding was localized to a
13 kDa chymotryptic fragment that included a type-3, N-terminal
CH domain [16]. The large contact surface required for the tropo-
myosin interaction with CHASM is not unusual since other tropo-
myosin-binding proteins have binding interfaces that extend over
many dozens of amino acids. For example, two TBDs identiﬁed in
tropomodulin extend over the N-terminal half of the protein (res-
idues 1–48 and 90–184; showing speciﬁcity for skeletal muscle
and erythrocyte tropomyosins, respectively [23,24]). Furthermore,
sequences near the boundaries of these binding regions were also
deemed important for proper folding and interface of tropomodu-
lin with tropomyosin. Our Kd value, obtained by ITC, for the binding
of CHASM with smooth muscle a/b tropomyosin was in line with
other previously examined tropomyosin interactions. The reported
Kd value was 106 M for the tropomodulin association with
tropomyosin [24]. In future studies, it will be important to deﬁne
the location of the CHASM binding domain on tropomyosin anddetermine the efﬁciencies of CHASM binding for skeletal muscle
tropomyosin since a histological examination of muscle beds dem-
onstrated a high expression of CHASM protein in Types I and 2a
striated muscle ﬁbers [2].
Most proteins that possess CH domains can bind F-actin, yet
studies have consistently concluded that a single CH domain is
not sufﬁcient for this biological property [26]. In a previous report,
we have demonstrated that CHASM lacks F-actin binding charac-
teristics in vitro [1], so the precise role of the single CH domain
in CHASM was undeﬁned. Our ﬁnding that GFP–CHASM, but not
GFP–CHASM-DCT, was associated with ﬁlaments in cultured
A7r5 smooth muscle cells suggests that the CH domain contributes
to the tropomyosin-binding properties of CHASM and enables the
targeting of the protein to contractile ﬁlaments. It has been previ-
ously suggested that phosphorylation-dependent changes in the
biological activity of CHASM and the protein’s effects on muscle
contractility did not occur via direct inhibitory mechanisms but
rather through interactions with the contractile ﬁlament [2]. It
bears emphasis that the PKG-dependent phosphorylation site
(i.e., Ser-301) is located within the putative tropomyosin-binding
region of CHASM, and thus, phosphorylation could have a signiﬁ-
cant effect on the localization of the protein to thin-ﬁlaments. Fu-
ture studies will be required to provide insight into the spatial
localization of phosphorylated CHASM and its in vivo effects on
the smooth muscle thin ﬁlament system.
We have previously demonstrated that the CH domain of
CHASM possesses a calmodulin (CaM)-binding IQ-motif, and this
domain could mediate an interaction with the two Ca2+-binding
loop regions contained within the C-domain of apo-CaM [3]. In
the present study, our examination of the CHASM interaction with
tropomyosin revealed that the CH domain was also required.
The binding afﬁnity of CHASM-DTBD for either apo-CaM or
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DTBD (Kd = 8.7  106 M) was only slightly higher than that deter-
mined for tropomyosin (Kd = 2.0  106 M). These results imply
that apo-CaM-binding may be interrupted with tropomyosin asso-
ciation and vice versa. However, it is also possible that the contri-
bution of the CH-domain to apo-CaM- and/or tropomyosin-binding
is not mutually exclusive. We have collected preliminary biophys-
ical evidence that indicates deletion of the ‘KTKKK’ C-terminal tail
abrogates apo-CaM-binding (MacDonald, unpublished data) while
NMR signals originating from the ‘KTKKK’ tail-sequence of CHASM
were not suppressed by tropomyosin binding (Ishida, H. unpub-
lished data). Therefore, apo-CaM and tropomyosin may not share
the same precise interface on the CH domain. While future studies
are required to assess whether a heteromultimeric complex of
CHASM, apo-CaM and tropomyosin exist in situ, our ﬁndings do
suggest that the CH domain of CHASM provides a binding surface
for tropomyosin as well as apo-CaM, thus placing CHASM in a un-
ique position to inﬂuence thin-ﬁlament structure as well as Ca2+-
regulated contraction.
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